| Decitabine studied in …STUDIED_INderived200 of 287show all (up to 200) |
|---|
| → studied in | NCT03418038Phase 2 · recruiting Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia · 287 trials list this drug (70 active) | — | — | Lymphoma,Hodgkin Lymphoma,Chronic Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06401603Phase 1 · recruiting A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03661307Phase 1/Phase 2 · recruiting Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07012044Phase 1 · recruiting A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia,Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05201066Phase 2 · active not recruiting Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab. · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801489Phase 2 · recruiting Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · 287 trials list this drug (70 active) | — | — | De Novo Myelodysplastic Syndrome,Myelodysplastic Syndrome with Excess Blasts,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06561074Phase 2 · recruiting A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy) · 287 trials list this drug (70 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04282187Phase 2 · recruiting Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm,Myeloproliferative Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01861314Phase 1 · active not recruiting Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia Post Cytotoxic Therapy+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02890329Phase 1 · active not recruiting Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,Secondary Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06383572Phase 1/Phase 2 · recruiting Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06429098Phase 2 · active not recruiting Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03875287Phase 1 · active not recruiting Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors · 287 trials list this drug (70 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06930651Phase 1/Phase 2 · recruiting A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03013998Phase 2/Phase 3 · recruiting Study of Biomarker-Based Treatment of Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07177079Phase 1 · recruiting High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML) · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07163793Phase 2 · active not recruiting Pilot Study of Reduced Venetoclax Exposure · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04874480Phase 1 · active not recruiting Tegavivint for the Treatment of Relapsed or Refractory Leukemia · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07773909Phase 4 · completed Venetoclax With Hypomethylating Agents in Newly Diagnosed AML Unfit for Intensive Chemotherapy · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05796570Phase 2 · active not recruiting A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies · 287 trials list this drug (70 active) | — | — | Myeloid Neoplasm,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07148947Phase 2 · recruiting Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms · 287 trials list this drug (70 active) | — | — | Accelerated Phase Myeloproliferative Neoplasm,Blast Phase Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01515527Phase 2 · recruiting Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06997094Phase 1 · recruiting Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer · 287 trials list this drug (70 active) | — | — | Head and Neck Squamous Cell Carcinoma,Human Papillomavirus-Independent Squamous Cell Carcinoma,Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03969446Phase 1 · suspended Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05038592Phase 1/Phase 2 · active not recruiting Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes · 287 trials list this drug (70 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm,Chronic Myelomonocytic Leukemia,Chronic Myelomonocytic Leukemia-1+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02650986Phase 1/Phase 2 · active not recruiting Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1 · 287 trials list this drug (70 active) | — | — | Malignant Solid Neoplasm,Melanoma,Primary Peritoneal Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02957968Phase 2 · active not recruiting Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca · 287 trials list this drug (70 active) | — | — | Malignant Breast Neoplasm,Breast Adenocarcinoma,Invasive Breast Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07216833Phase 1 · withdrawn Decitabine and Nivolumab in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck · 287 trials list this drug (70 active) | — | — | Head and Neck Neoplasm,Malignant Head and Neck Neoplasm,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03041688Phase 1 · active not recruiting Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03146871Phase 2 · terminated Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04188405Phase 2 · completed Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous Leukemia · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia,Chronic Myeloid Leukemia, BCR-ABL1 Positive,Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07617363Phase 1 · not yet recruiting ATRN-119 in Combination With Decitabine in Patients With TP53-Mutated AML or Higher-Risk MDS · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564650Phase 1 · completed Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07594899Phase 2 · not yet recruiting AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04187703early Phase 1 · recruiting 5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06928662Phase 1/Phase 2 · recruiting Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05829226Phase 1 · completed A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS) · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07374029Phase 1 · recruiting Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05586074Phase 3 · recruiting HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01627041Phase 2 · active not recruiting Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia,Alkylating Agent-Related Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06129734Phase 1/Phase 2 · recruiting Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03164057Phase 2 · active not recruiting A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06802146early Phase 1 · recruiting Early Intervention in High Risk CCUS · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03009240Phase 1 · completed Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia Post Cytotoxic Therapy+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05222984Phase 1 · active not recruiting Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03132454Phase 1 · active not recruiting Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory Leukemia · 287 trials list this drug (70 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03240211Phase 1 · active not recruiting Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL · 287 trials list this drug (70 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03017131Phase 1 · active not recruiting Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · 287 trials list this drug (70 active) | — | — | Primary Peritoneal Carcinoma,Ovarian Carcinoma,Fallopian Tube Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07511062Phase 1 · not yet recruiting Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06327685Phase 1 · recruiting Avapritinib With Decitabine in Patients With SM-AHN · 287 trials list this drug (70 active) | — | — | Systemic Mastocytosis with an Associated Myeloid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07505160Phase 2 · not yet recruiting Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04980404Phase 1 · active not recruiting Inqovi Maintenance Therapy in Myeloid Neoplasms · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia,Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03226418Phase 2 · completed Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Post Cytotoxic Therapy,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03404193Phase 2 · terminated Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03844815Phase 1 · active not recruiting Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07044544Phase 1 · recruiting Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies · 287 trials list this drug (70 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07283094Phase 1 · recruiting FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03358719Phase 1 · completed DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06511882Phase 2 · recruiting Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03974217Phase 1 · active not recruiting Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07389239Phase 1/Phase 2 · not yet recruiting A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies. · 287 trials list this drug (70 active) | — | — | Malignant Solid Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03445858early Phase 1 · completed Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults · 287 trials list this drug (70 active) | — | — | Malignant Neoplasm,Adult Solid Neoplasm,Childhood Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05455294Phase 1 · active not recruiting Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Myeloproliferative Neoplasm,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02961101Phase 1/Phase 2 · recruiting Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03926624Phase 3 · terminated Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05799079Phase 2 · terminated Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05184842Phase 2 · recruiting Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06803693Phase 2 · recruiting Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL · 287 trials list this drug (70 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05918055Phase 1/Phase 2 · terminated Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03263936Phase 1 · completed Epigenetic Reprogramming in Relapse/Refractory AML · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04229979Phase 3 · active not recruiting Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2 · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03019003Phase 1 · completed Oral Decitabine (ASTX727) and Durvalumab in Recurrent and/or Metastatic Head and Neck Cancer Patients · 287 trials list this drug (70 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02269280Phase 2 · completed Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06474663Phase 1 · withdrawn A Phase I Study Investigating the Combination of Cladribine, Low Dose Cytarabine and Sorafenib Alternating With Decitabine in Pediatric Relapsed and Refractory Acute Leukemias · 287 trials list this drug (70 active) | — | — | Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04891757Phase 1 · active not recruiting FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies · 287 trials list this drug (70 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Myelodysplastic Syndrome,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07052422Phase 2/Phase 3 · not yet recruiting VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02257138Phase 1/Phase 2 · completed Ruxolitinib Phosphate and Decitabine in Treating Patients With Relapsed or Refractory or Post Myeloproliferative Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07007767Phase 2 · not yet recruiting Exploring Sintilimab + Bevacizumab + Decitabine for Advanced pMMR/MSS Colorectal Cancer (After 2+ Prior Therapies） · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06572631Phase 1 · withdrawn Multi-antigen Specific CD8+ T Cells With Decitabine and Lymphodepleting Chemotherapy for the Treatment of Patients With Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Transplantation From a Matched Donor · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03066648Phase 1 · completed Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS · 287 trials list this drug (70 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06972641Phase 2/Phase 3 · recruiting Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03063944Phase 1 · completed STAT Inhibitor OPB-111077, Decitabine and Venetoclax in Treating Patients With Acute Myeloid Leukemia That Is Refractory, Relapsed or Newly Diagnosed and Ineligible for Intensive Chemotherapy · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06686108Phase 2 · recruiting Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention · 287 trials list this drug (70 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05766514Phase 2 · withdrawn Trial of Cladribine and Low-Dose Cytarabine (LoDAC) Alternating With Decitabine vs. Hypomethylating Agents (HMA) Plus Venetoclax as Frontline Therapy for AML or High-Grade MDS in Patients Unfit for Intensive Induction · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04277442Phase 1 · completed Testing Nivolumab in Combination With Decitabine and Venetoclax in Patients With Newly Diagnosed TP53 Gene Mutated Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05360264Phase 2 · terminated tailOred dRug repurposIng of dEcitabine in KRAS-dependeNt refracTory pAncreaTic cancEr · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05190471Phase 1 · recruiting A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML) · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03092674Phase 2/Phase 3 · completed Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02488408Phase 1/Phase 2 · completed A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02085408Phase 3 · completed Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05177731Phase 3 · active not recruiting Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML · 287 trials list this drug (70 active) | — | — | Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04097470Phase 2 · active not recruiting Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02664181Phase 2 · completed Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With NSCLC: PRECISE Trial · 287 trials list this drug (70 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03306264Phase 3 · completed Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06316960Phase 2 · recruiting Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia,Childhood Acute Myeloid Leukemia,Core Binding Factor Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042003Phase 2 · completed Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec) · 287 trials list this drug (70 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00043381Phase 3 · completed Decitabine Versus Supportive Care in Adults With Advanced-stage MDS · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06357858Phase 1 · withdrawn ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck · 287 trials list this drug (70 active) | — | — | Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05740449Phase 1/Phase 2 · withdrawn HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological Malignancies · 287 trials list this drug (70 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06337331Phase 2 · withdrawn Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06297772Phase 3 · not yet recruiting Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR · 287 trials list this drug (70 active) | — | — | Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06441097Phase 2 · not yet recruiting Efficacy of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL · 287 trials list this drug (70 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04905810Phase 2 · recruiting Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05524857Phase 1 · terminated Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP) · 287 trials list this drug (70 active) | — | — | Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04113616Phase 1/Phase 2 · terminated An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML) · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02632721Phase 1/Phase 2 · completed A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML) · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06046313Phase 2 · recruiting Prolonged Ultra Low-dose Decitabine Plus Venetoclax for Primary Diagnosed Elderly AMLK/MDS · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02441803Phase 2 · completed Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01812252Phase 2 · completed Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Secondary Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05983276Phase 2 · recruiting Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer · 287 trials list this drug (70 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02608268Phase 1/Phase 2 · terminated Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04055844Phase 2 · completed Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04485052Phase 1/Phase 2 · suspended Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02073838Phase 2 · completed Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02959164Phase 1 · completed Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma · 287 trials list this drug (70 active) | — | — | Sarcoma,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233724Phase 1/Phase 2 · terminated Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas · 287 trials list this drug (70 active) | — | — | Malignant Lung Neoplasm,Esophageal Carcinoma,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04146038Phase 2 · completed Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Myeloproliferative Neoplasm,Secondary Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02203773Phase 1 · terminated Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML) · 287 trials list this drug (70 active) | — | — | Myeloid Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05805072NA · unknown Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02878785Phase 1/Phase 2 · completed Decitabine and Talazoparib in Untreated AML and R/R AML · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05351346Phase 3 · unknown Genotype-guided Treatment in DLBCL · 287 trials list this drug (70 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03941964Phase 3 · completed A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy · 287 trials list this drug (70 active) | — | — | Malignant Neoplasm,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01420926Phase 2 · completed Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03303339Phase 1/Phase 2 · completed Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML) · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02172872Phase 3 · unknown "InDACtion" vs "3+7" Induction in AML · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02996474Phase 1/Phase 2 · completed Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01882660NA · terminated Pre-operative Decitabine in Colon Cancer: a Proof of Principle Study · 287 trials list this drug (70 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05638984Phase 2 · unknown Low Dose Decitabine in Combination With Tirelizumab Comparison of Tirelizumab in the First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03855371Phase 1 · unknown Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03709550Phase 1/Phase 2 · withdrawn Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer · 287 trials list this drug (70 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01673217Phase 1 · completed Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer · 287 trials list this drug (70 active) | — | — | Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01834248Phase 1 · completed DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05449899Phase 2/Phase 3 · unknown G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02109744Phase 1/Phase 2 · completed Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01177540Phase 2 · terminated Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects · 287 trials list this drug (70 active) | — | — | Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01303796Phase 3 · completed A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04655391Phase 1 · withdrawn Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03063203Phase 2 · terminated Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05382390Phase 3 · unknown Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05320640Phase 1/Phase 2 · unknown Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors · 287 trials list this drug (70 active) | — | — | Solid Neoplasm,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03295552Phase 2 · terminated Decitabine Plus Carboplatin in the Treatment of Metastatic TNBC · 287 trials list this drug (70 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01893320Phase 1/Phase 2 · completed Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02214407Phase 3 · completed Randomized Phase III Study of Decitabine +/- Hydroxyurea (HY) Versus HY in Advanced Proliferative CMML · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04051996Phase 2 · terminated GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04252248Phase 1 · terminated Decitabine Treatment in HPV-Induced Anogenital and Head and Neck Cancer Patients After Radiotherapy or as Novel Late Salvage · 287 trials list this drug (70 active) | — | — | Head and Neck Neoplasm,Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03467178Phase 2 · unknown Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer. · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02190695Phase 2 · completed Leukemia SPORE Phase II DAC Study for R/R and Elderly Acute AML and MDS · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03080766Phase 2 · unknown The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03113071Phase 1/Phase 2 · terminated Safety and Activity of Digoxin With Decitabine in Adult AML and MDS · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04283526Phase 1 · withdrawn Study of Select Combinations in Adults With Myelofibrosis · 287 trials list this drug (70 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01720225Phase 2 · completed Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03530085Phase 2/Phase 3 · unknown Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04553393Phase 1/Phase 2 · unknown Decitabine-primed Tandem CD19/CD20 CAR T Cells Plus Epigenetic Agents in Aggressive r/r B-NHL With Huge Tumor Burden · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04025593Phase 2 · unknown Biomarker Guided Treatment in DLBCL · 287 trials list this drug (70 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04493099Phase 1/Phase 2 · withdrawn Alvocidib in Combination With Decitabine and Venetoclax in Patients With Relapsed or Refractory AML or as Frontline Therapy in Unfit Patients With AML · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01483690Phase 1/Phase 2 · terminated A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL · 287 trials list this drug (70 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01498445Phase 1/Phase 2 · terminated An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357) · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04233294Phase 2 · unknown Addition of Chidamide to the Combination Treatment of Decitabine Plus Camrelizumab in Combination Treatment Resistant/Relapsed Patients With Classical Hodgkin Lymphoma · 287 trials list this drug (70 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04279379Phase 2 · unknown Sintilimab and Decitabine for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma · 287 trials list this drug (70 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04353479Phase 2 · unknown Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01786343Phase 2 · completed Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML) · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04337606Phase 1/Phase 2 · unknown Chidamide in Combination With Decitabine in Non-Hodgkin's Lymphoma Relapsed After Chimeric Antigen Receptor · 287 trials list this drug (70 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02252107Phase 2 · completed 10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1 · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02921061Phase 1/Phase 2 · completed Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02951728Phase 1/Phase 2 · unknown Decitabine Plus R-CHOP in Diffuse Large B-cell Lymphoma · 287 trials list this drug (70 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03793517Phase 2/Phase 3 · recruiting Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02316964Phase 1 · completed Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Secondary Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia,Acute Myeloid Leukemia with del(5q)+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01546038Phase 2 · completed A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04292769Phase 3 · unknown Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors · 287 trials list this drug (70 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02010645Phase 2 · terminated Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS) · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01707004Phase 2 · completed Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02954653Phase 1 · terminated A Study Of PF-06747143, As Single Agent Or In Combination With Standard Chemotherapy In Adult Patients With Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02343939Phase 1/Phase 2 · terminated Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML) · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02129101Phase 1 · completed Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm,Chronic Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04123392Phase 2/Phase 3 · unknown Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00037817Phase 1 · completed Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies · 287 trials list this drug (70 active) | — | — | Malignant Esophageal Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04098653Phase 2/Phase 3 · unknown Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT · 287 trials list this drug (70 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02634827Phase 2 · terminated Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation · 287 trials list this drug (70 active) | — | — | Secondary Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia,Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01794702Phase 1/Phase 2 · completed Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03799224Phase 2/Phase 3 · unknown Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00414310Phase 2 · completed Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03250962Phase 2 · unknown SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma · 287 trials list this drug (70 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01165996Phase 1/Phase 2 · completed Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Myelodysplastic Syndrome with Ring Sideroblasts,Chronic Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02076191Phase 1/Phase 2 · completed Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML · 287 trials list this drug (70 active) | — | — | Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416598Phase 2 · completed Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia,Acute Myeloid Leukemia, Myelodysplasia-Related,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01729845Phase 1/Phase 2 · completed Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02003573Phase 1 · terminated Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML) · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02323607Phase 1 · completed Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 Mutations · 287 trials list this drug (70 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Post Cytotoxic Therapy,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02412475Phase 1 · terminated Epigenetic Reprogramming in Relapse AML · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02847000early Phase 1 · completed p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic Cancer · 287 trials list this drug (70 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02846935early Phase 1 · completed p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies · 287 trials list this drug (70 active) | — | — | Non-Hodgkin Lymphoma,T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02785900Phase 3 · terminated Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia · 287 trials list this drug (70 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03346642Phase 1/Phase 2 · unknown Two Stage Study of Combination of Chemotherapy, SHR-1210 and/or Decitabine for Relapsed/Refractory PMBCLs · 287 trials list this drug (70 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085293Phase 2 · completed Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131 · 287 trials list this drug (70 active) | — | — | Thyroid Gland Follicular Carcinoma,Malignant Thyroid Gland Neoplasm,Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075010Phase 1/Phase 2 · completed Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes · 287 trials list this drug (70 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00903760Phase 2 · completed Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS) · 287 trials list this drug (70 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00791271Phase 1 · terminated Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion · 287 trials list this drug (70 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002831Phase 1/Phase 2 · completed Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02469415Phase 2 · terminated Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS) · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02264873Phase 1 · completed Phase I, Dose Escalation Study of Decitabine · 287 trials list this drug (70 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |